Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.62 |
| ▸ | EGFR | P00533 | 11/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | MAP3K8 | P41279 | 2/20 | 0.51 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | BRAF | P15056 | 1/20 | 0.46 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.44 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8483667 | 0.84 | EGFR (0.58) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL6993122 | 0.83 | EGFR (0.60) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL6994800 | 0.82 | EGFR (0.60) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL8490032 | 0.82 | EGFR (0.57) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL8318375 | 0.81 | EGFR (0.61) | EGFRERBB2HPGDHTTGRM1 | |
| SCHEMBL6989432 | 0.81 | STK17A (0.62) | EGFRERBB2HPGDHTTGRM1 | |
| SCHEMBL8490245 | 0.81 | EGFR (0.54) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL6990324 | 0.80 | STK17A (0.59) | EGFRERBB2HPGDHTTGRM1 | |
| SCHEMBL8315205 | 0.80 | EGFR (0.53) | CSNK2A1EGFRERBB2HPGDHTT | |
| SCHEMBL6993332 | 0.80 | EGFR (0.59) | EGFRERBB2HPGDHTTGRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977102-A | INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; | DR. KARL THOMAE GMBH (DE) | 1999-11-02 | — | — | US | disclosed |